1. Guanylate‐binding protein‐2 inhibits colorectal cancer cell growth and increases the sensitivity to paclitaxel of paclitaxel‐resistant colorectal cancer cells by interfering Wnt signaling
    Jing Wang et al, 2020, Journal of Cellular Biochemistry CrossRef
  2. Activation of Src mediates acquired cisplatin resistance in human lung carcinoma cells
    Guojun Jiang et al, 2020, Anti-Cancer Drugs CrossRef
  3. The pro- and anti-tumoral properties of gap junctions in cancer and their role in therapeutic strategies
    Maria C. Oliveira et al, 2022, Redox Biology CrossRef
  4. Connexin 32 affects doxorubicin resistance in hepatocellular carcinoma cells mediated by Src/FAK signaling pathway
    Meiling Yu et al, 2017, Biomedicine & Pharmacotherapy CrossRef
  5. Connexins—Therapeutic Targets in Cancers
    Magdalena Nalewajska et al, 2020, International Journal of Molecular Sciences CrossRef
  6. Genome-wide CRISPR-Cas9 screens identify mechanisms of BET bromodomain inhibitor sensitivity
    David Estoppey et al, 2021, iScience CrossRef
  7. CX43 down-regulation promotes cell aggressiveness and 5-fluorouracil-resistance by attenuating cell stiffness in colorectal carcinoma
    Yue Han et al, 2023, Cancer Biology & Therapy CrossRef
  8. Intercellular Communication in Cancer
    Abdullah Shaito et al, 2023, Handbook of Cancer and Immunology CrossRef
  9. Synergistic effect of a nonsteroidal anti-inflammatory drug in combination with topotecan on small cell lung cancer cells
    Sevinc Yanar et al, 2024, Molecular Biology Reports CrossRef
  10. All‐trans retinoic acid reverses epithelial‐mesenchymal transition in paclitaxel‐resistant cells by inhibiting nuclear factor kappa B and upregulating gap junctions
    Guiling Shi et al, 2019, Cancer Science CrossRef
  11. New Heterocyclic Combretastatin A-4 Analogs: Synthesis and Biological Activity of Styryl-2(3H)-benzothiazolones
    Gjorgji Atanasov et al, 2021, Pharmaceuticals CrossRef
  12. The Potential Impact of Connexin 43 Expression on Bcl-2 Protein Level and Taxane Sensitivity in Head and Neck Cancers–In Vitro Studies
    Bianka Gurbi et al, 2019, Cancers CrossRef
  13. Biological landscape and nanostructural view in development and reversal of oxaliplatin resistance in colorectal cancer
    Mehrdad Hashemi et al, 2024, Translational Oncology CrossRef